Profile
DYNT ABT BSX-PA SYK BSX MDT
Company Name Dynatronics Corporation Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $934.52K $234.21B $175.45B $150.29B $145.55B $122.61B
Employees 0.11K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Brian D. Baker Robert B. Ford Michael F. Mahoney Kevin A. Lobo Michael F. Mahoney Geoffrey Straub Martha
Ratings
DYNT ABT BSX-PA SYK BSX MDT
Quant Rating Score 3 4 3 3 3
Quant Rating Neutral Buy Neutral Neutral Neutral
Trading
DYNT ABT BSX-PA SYK BSX MDT
Last Close $0.075 $134.57 $122.18 $377.84 $98.23 $95.59
High 52 $0.19 $140.22 $122.18 $403.53 $108.14 $95.59
Low 52 $0.07 $111.1 $122.18 $337.28 $83.08 $79.61
Price vs. 52 Week High -60.53 % -4.03 % 0 % -6.37 % -9.16 % 0 %
Price vs. 52 Week Low 7.14 % 21.13 % 0 % 12.03 % 18.24 % 20.07 %
Total Return
DYNT ABT BSX-PA SYK BSX MDT
1 Month Return -16.67 % 2.53 % 0 % -3.15 % -5.32 % 6.33 %
3 Month Return -21.79 % 1.63 % 0 % 1.23 % -3.1 % 11.5 %
6 Month Return -41.41 % 5.61 % 0 % -0.06 % -2.48 % 4.05 %
9 Month Return -43.4 % 19.7 % 0 % 5.8 % 10.79 % 19.5 %
YTD Return -38.12 % 18.97 % 0 % 4.94 % 9.98 % 19.67 %
1 Year Return -46.43 % 17.89 % 0 % 3.5 % 17.35 % 6.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DYNT ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 1.72 % - 0.84 % - 2.94 %
Dividend Paid and Capex Coverage Ration (TTM) 14.15 % 1.45 % 4.3 % 2.39 % 4.3 % 1.31 %
Dividend Per Share (TTM) - 2.32 % - 3.32 % - 2.81 %
Payout Ratio (TTM) - 28.42 % 0.92 % 42.87 % 0.92 % 77.26 %
Profitability
DYNT ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM 22.56 % 52.79 % 63.23 % 62.19 % 63.23 % 63.44 %
Return on Assets TTM -12.86 % 16.64 % 6.02 % 6.3 % 6.02 % 5.12 %
Return on Equity TTM -22.77 % 29.93 % 11.49 % 14.08 % 11.49 % 9.62 %
Return on Capital Employed TTM -15.85 % 10.7 % 8.53 % 13.86 % 8.53 % 7.71 %
Net Income Per EBT TTM 107.1 % 176.99 % 83.43 % 87.08 % 83.43 % 82.32 %
EBT Per Ebit TTM 116.3 % 104.64 % 96.68 % 61.93 % 96.68 % 92.49 %
EBIT Per Revenue TTM -8.52 % 17.51 % 16.77 % 22.72 % 16.77 % 17.9 %
Cash Flow To Debt Ratio TTM 7.94 % 67.25 % 35.63 % 27.83 % 35.63 % 24.98 %
Receivables Turnover TTM 9.43 4.21 6.57 6.08 6.57 5.46
Payables Turnover TTM 5.95 4.73 7.07 6.25 7.07 4.89
Inventory Turnover TTM 4.03 2.93 2.38 1.7 2.38 -33.52
Fixed Asset Turnover TTM 698.7 % 378.32 % 467.97 % 560.03 % 467.97 % -6785.71 %
Asset Turnover TTM 121.23 % 51.32 % 44.5 % 51.41 % 44.5 % 37.59 %
Operating Cash Flow Per Share TTM 0.05 5.19 2.9 12.47 2.9 5.58
Free Cash Flow Per Share TTM 0.05 3.89 2.24 10.53 2.24 4.14
Cash Per Share TTM 1.98 % 418.4 % 36.12 % 644.69 % 36.12 % 633.66 %
Operating Cash Flow Sales Ratio TTM 1.62 % 20.96 % 23.17 % 20.01 % 23.17 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 92.93 % 74.97 % 77.27 % 84.43 % 77.27 % 74.21 %
Cash Flow Coverage Ratios TTM 7.94 % 67.25 % 35.63 % 27.83 % 35.63 % 24.98 %
Price To Free Cash Flows Ratio TTM 2.18 34.57 44.3 37.35 43.96 23.12
Price To Operating Cash Flows Ratio TTM 1.68 25.92 34.15 31.52 33.89 17.14
Price Cash Flow Ratio TTM 1.68 25.92 34.15 31.52 33.89 17.14
Income Statement (TTM)
DYNT ABT BSX-PA SYK BSX MDT
Revenue $0.03B $41.95B $16.75B $22.6B $16.75B $33.54B
Gross Profit $0.01B $21.33B $10.27B $13.98B $10.27B $21.91B
Gross Profit Ratio 23.47% 50.83% 61.31% 61.87% 61.31% 65.32%
EBITDA $-0B $10.83B $3.94B $4.94B $3.94B $9.22B
Net Income $-0B $13.4B $1.85B $2.99B $1.85B $4.66B
EPS Diluted -1 7.64 1.25 7.76 1.25 3.61
Balance Sheet (MRQ)
DYNT ABT BSX-PA SYK BSX MDT
Long Term Debt $0B $13.52B $9.37B $12.57B $9.37B $25.64B
Total Liabilities $0.01B $33.51B $17.39B $22.34B $17.39B $43.42B
Total Equity $0.01B $47.9B $22B $20.63B $22B $48.26B
Total Investments $0B $1.24B $0.56B $0.88B $0.56B $6.75B
Total Debt $0.01B $15.28B $11.15B $14.12B $11.15B $28.52B
Total Assets $0.03B $81.41B $39.4B $42.97B $39.4B $91.68B
Cash Flow Statement (TTM)
DYNT ABT BSX-PA SYK BSX MDT
Net Income $-0B $13.4B $1.85B $2.99B $1.85B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.21B $-0.23B $-0.29B
Dividends Paid $0B $-3.84B $0B $-1.22B $0B $-3.59B
Operating Cash Flow $-0B $8.56B $3.44B $4.24B $3.44B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.76B $-0.79B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 136.21
ADGM Adagio Medical Holdings, Inc. 1.74
AEMD Aethlon Medical, Inc. 0.7406
AFIB Acutus Medical, Inc. 0.0004
AHCO AdaptHealth Corp. 9.0522
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 130.61
ALUR Allurion Technologies Inc. 2.08
AMIX Autonomix Medical, Inc. Common Stock 1.09
ANIK Anika Therapeutics, Inc. 8.925
AORT Artivion, Inc. 40.94
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.26
ARAY Accuray Incorporated 1.705
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 15.4518
AVNS Avanos Medical, Inc. 12.03
AVR Anteris Technologies Global Corp. Common Stock 5.34
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to DYNT
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 211.97
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 161.61
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 161.62
VEMPX Vanguard Extended Market Index InstlPlus 0 398.83
Unlock